coronavirus vaccine maker Bharat Biotech is conducted in partnership with top medical body Indian Council of Medical Research (ICMR).The trials of its Covid-19 vaccine candidate -- Covaxin -- which involves 26,000 participants across 22 sites in the country, began on 16 November.
It is the largest clinical trial conducted for a coronavirus vaccine in India.The Covaxin phase 3 trials have commenced in several states in the country, including Delhi, Karnataka and Bengal, and many other states are expected to begin soon.States that have started the phase 3 trials of India's first Covid-19 vaccine:1) Haryana - Haryana became the first state to start Covaxin phase 3 trials on 20 November with state home minister Anil Vij being the first.